Cell group
Science that transforms
Applied Research for Health and Science
At Grupo Célula we have set out to create knowledge, transform data into real solutions and establish alliances that solve urgent needs in diagnostic medicine, public health and applied science.
With more than 5 years of experience in research and an interdisciplinary team with strategic vision, we are ready to co-create, lead and execute projects with impact.
We are recognized by MinCiencias as a research group and classified in Category C (National Call 957 of 2024).
WHAT DO WE DO?
Applied research with purpose
Since our inception in 2019, we have one key objective: innovation that impacts health, society and the future.
Today we develop our own and collaborative projects in 5 key lines:
- Molecular Pathology and Advanced Diagnostics
- Sports Medicine
- ICT Analytics and Transformation
- Specialized Diagnostic Medicine
- Strategic Communication in Science and Health
WHAT SETS US APART?
One cell, infinite connections.
Cross-cutting and scalable approach: from DNA to system, from data to impact.
Strategic allies: experience collaborating with research centers, universities, pharmaceutical and food industries.
Applied talent: scientific team with technical skills, business vision and social sensitivity.
Measurable solutions: our projects generate products, processes and services that can be scaled and transferred.
Who do we work for?
If you represent a university, pharmaceutical or food company, clinical research center or public entity, here's what we can do together:
- Co-design and execute R&D&I projects.
- To put our laboratory infrastructure and technical staff at the disposal of your clinical studies.
- To develop innovative solutions in diagnosis, treatment or prevention.
- Manage results for publication or transfer.
- Strengthen the scientific training of your team or students.
Research services
- Processing and analysis of human clinical samples under Good Clinical Practice standards.
- Accompaniment and development of research protocols.
- Design of outreach and scientific communication strategies.
Create with us the next healthcare solution
Do you have an idea, a challenge or a project in mind? Let's talk about it.
We serve the main insurance companies.
Learn about the health care benefits covered by your plan.
Scientific publications
Genetic variants in triglyceride metabolism genes among individuals with hypertriglyceridemia in Colombia.
Journal of Clinical Lipidology - 2024
Choosing Wisely in Endocrinology: Recommendations from an Expert Panel of the Colombian Association of Endocrinology, Diabetes, and Metabolism.
Colombian Journal of Endocrinology, Diabetes & Metabolism -2024
Obligatory System of Quality Assurance in Health: application to the clinical laboratory.
Medicine & Laboratory - 2023
Hemochromatosis: clinical and diagnostic update.
Medicine & Laboratory - 2023
Real-time PCR for the detection and genotyping of p.C282Y and p.H63D mutations in the HFE gene associated with hemochromatosis (qPCR HFE).
Medicine & Laboratory - 2023
Bacterial diversity analysis of freshwater sources for human use in rural areas of the tropical Andean region of Colombia.
Infectio - 2022.
Evaluation of new Toxocara canis chimeric antigens as an alternative to conventional TES-Ag for anti-Toxocara antibodies detection.
Heliyon - 2022.
Hypertrophic cardiomyopathy in a patient with secondary hypoparathyroidism: A case report.
Radiology Case Reports - 2022.
Human papillomavirus (HPV) and cancer.
Medicine & Laboratory - 2021
Evaluation of thyroid nodules with rapid on-site cytologic interpretation (ROSE).
Medicine & Laboratory - 2021
Microbiological diagnosis in bronchoalveolar lavage. Literature review.
Medicine & Laboratory - 2021
The Paris System "Atypical Urothelial Cells" Category: Can the current criteria be improved?
Journal of the American Society of Cytopathology - 2021.
Development and Validation of an In-House Library for Filamentous Fungi Identification by MALDI-TOF MS in a Clinical Laboratory in Medellin (Colombia)
Microorganisms - 2020
High frequency of gram-negative bacilli harboring blaKPC-2 in the different stage of wastewater treatment plant: A successful mechanism of resistance to carbapenems outside the hospital settings.
Medicine & Laboratory - 2023
Real-time PCR for the detection and genotyping of p.C282Y and p.H63D mutations in the HFE gene associated with hemochromatosis (qPCR HFE).
Journal of Environmental Management - 2020
Combretastatin A-4: The Antitubulin Agent that Inspired the Design and Synthesis of Styrene and Spiroisatin Hybrids as Promising Cytotoxic, Antifungal and Antiviral Compounds
Journal of the Brazilian Chemical Society - 2020
Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage
BMC Research Notes - 2019
Histological Transformation to Small Cell Carcinoma of an Adenosquamous Carcinoma of the Lung With Epidermal Growth Factor Receptor Mutation in Exons 20 and 21 After Treatment With Erlotinib: Case Report.
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine - 2019
ITS rDNA Gene Analysis Versus MALDI-TOF MS For Identification of Neoscytalidium dimidiatum Isolated from Onychomycosis and Dermatomycosis Cases
Microorganisms - 2019
Preoperative vitamin D deficiency is a risk factor for postoperative hypocalcemia in patients undergoing total thyroidectomy: Retrospective cohort study.
Sao Paulo Medical Journal - 2019
Projects
High-risk human papillomavirus genotypes as predictors of the development of high-grade cervical lesions in a population of women aged 18 to 65 years attending a health institution in Medellin Colombia between 2021 and 2024.
Objective: To evaluate variables of the different high-risk HPV types that may help predict the occurrence of cervical cancer.
Cell Group Role: Executing Institution.
Duration: 2024-current
Grip strength in a population of Brazilian jiu-jitsu competitors: descriptive study in the context of the Medellín PRO BJJ 3 tournament.
Objective: To evaluate if the specific hand and grip strength is associated to training variables such as experience, training level, power and related, in turn, to better competitive results.
Cell Group Role: Protocol design, analysis of results.
Partner: CES University - Faculty of Medicine.
Duration: 2024-current
Result: Dissemination in Medellín PRO BJJ 4 sporting event.
Maximizing diagnostic certainty: thyroid nodule rapid diagnostic program.
Objective: To evaluate the diagnostic capability of ultrasound and cytology compared to histopathological result in thyroid nodules; using the ROSE (Rapid On Site Evaluation) technique.
Cell Group Role: Executing Institution.
Duration: 2023-present.
Characterization of lipid profile alterations in pediatric patients with subclinical hypothyroidism.
Objective: Characterize alterations in the lipid profile in children with subclinical hypothyroidism between 3 years and 17 years 11 months and 29 days of age.
Cell Group Role: Data generation.
Partner: Universidad de Antioquia - School of Medicine.
Duration: 2023-present.
Comparison of analytical quality in hemostasis tests of samples obtained with the BD Vacutainer® UltraTouch™ and BD Vacutainer® Safety-Lok™ winged devices in patients attending the Laboratorio Clínico Hematológico (Medellín, Colombia).
Objective: To compare hemostasis results (PT, PTT and PFA) in samples obtained with the BD Vacutainer® UltraTouch™ Push Button 23 G system with respect to BD Vacutainer® Safety-Lok™ 21 G.
Cell Group Role: Executing Institution.
Funder: Beckton Dickinson
Duration: 2023-current.
Strengthening of the Scientific Dissemination Program by the Hematologico
Objective: To improve the dissemination of scientific knowledge focused on diagnostic medicine and its advances.
Cell Group Role: Executing Institution.
Duration: 2022-current
Outcome: Master's student training.
IT Strengthening in Hematology: Software, Telecommunications and Security Solutions
Objective: To apply information technologies to improve diagnostic processes, service optimization and decision making in diagnostic medicine.
Cell Group Role: Executing Institution.
Duration: 2022-actual
Prevalence of genetic alterations of lipid metabolism in individuals with severe hypertriglyceridemia in Colombia.
Objective: Estimate the prevalence of pathogenic variants in triglyceride metabolism genes among patients with severe hypertriglyceridemia and/or episodes of pancreatitis that are not of biliary or alcoholic origin.
Cell Group Role: Sample collection and analysis. DNA extraction.
Partner: Universidad de Los Andes - School of Medicine.
Duration: 2020-2024
Result: Publication in an indexed journal.
Evaluation of platelet function according to the transport and storage conditions of patient samples from the Laboratorio Clínico Hematológico, Medellín 2021.
Objective: Evaluate the stability of samples for platelet function tests and explore the association between sample stability according to acceleration and time.
Cell Group Role: Executing Institution.
Partner: Universidad de Antioquia - School of Microbiology.
Duration: 2019-2023
Outcome: Master's student training.
Changes in muscle ultrasound, physical capacities, blood tests and anthropometry in university students following a health exercise protocol
Objective: To evaluate and compare anthropometric and ultrasound measurements used to quantify the effects of strength training.
Cell Group Role: Sample collection and analysis.
Partner: Politécnico Colombiano Jaime Isaza Cadavid - Faculty of Physical Education, Recreation and Sport.
Duration: 2018-2025
Result: Publications in indexed journals.
Our Team
Jairo Alonso Mesa Arango
MB, PhD.
Cell Group Director. Molecular scientist.
Germán Campuzano Zuluaga, MD.
Computer Pathologist
Physician with specializations in Anatomic Pathology and Laboratory Medicine, and sub-specialization in Hematopathology. In addition, training in computer pathology.
Verónica Johanna Tangarife Castaño, MB, MSc.
Science communicator
Microbiologist with a master's degree in Social Communication of Scientific Research and a master's degree in Basic Biomedical Sciences.
Laura Joanna Tapia Vela
MD.
Cytopathologist
Physician with specialization in Pathology, Master's student in Epidemiology.
